数据链接：
官方服务：
资源简介：
Medication combinations used to treat COVID-19.
用于治疗新型冠状病毒肺炎（COVID-19）的联合用药方案
应用场景：
创建时间：
2021-06-11
相关数据集
SUPPLEMENTARY FILE 2. THE ASSOCIATION BETWEEN CONVALESCENT PLASMA AND THE RISK OF MORTALITYSupplementary file 2: Association between convalescent plasma and the risk of mortality among patients with COVID-19: A meta-analysis
Supplementary file 2. The association between convalescent plasma and the risk of mortality.Association between convalescent plasma and the risk of mortality among patients with COVID-19: A meta-analy
DataCite Commons2021-04-05 更新90
REPOSITORY COMVIVIR .xlsx
This research evaluated the effect of Maraviroc and/or Favipiravir plus systemic steroids versus systemic steroids only on the viral load of adults with severe COVID-19: clinical trials .COVID-19 has
DataCite Commons2024-01-23 更新70
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
This phase II trial studies how well TAS-102 and oxaliplatin work in treating patients with stage IV colon cancer. Drugs used in chemotherapy, such as TAS-102 and oxaliplatin, work in different ways t
NIAID Data Ecosystem60
Supplementary Material for: Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial
Introduction: Immunomodulatory therapies have shown beneficial effects in patients with severe COVID-19. Patients with hypercytokinemia might benefit from the removal of inflammatory mediators via hem
Mendeley Data2024-06-25 更新90
Use of medicines for covid-19 treatment in patients with loss of kidney function: a narrative review
ABSTRACT Covid-19 has been identified as the cause of acute respiratory disease with interstitial and alveolar pneumonia, but it can affect several organs, such as kidneys, heart, blood, nervous syste
DataCite Commons2021-03-25 更新60
